Correlation Between Serum Chloride and Anion Gap Levels in DKA Patients
NCT ID: NCT05598866
Last Updated: 2022-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
54 participants
OBSERVATIONAL
2022-10-31
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To examine the description and correlation of changes in the serum chloride levels and changes in the anion gap values before and after fluid resuscitation in patients with DKA and to examine the description and correlation of changes in the serum chloride.
2. relation of serum chloride and outcome in patients with DKA
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Children with Diabetic Ketoacidosis
NCT06599203
Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic Complications
NCT05443802
Impact of Blood Glucose Levels on in ICU Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
NCT06453967
Incidence, Characterisation and Outcome-relevance of Perioperative SGLT2 Inhibitor Associated Ketoacidosis
NCT06838507
Glycemic Gap Versus Admission Plasma Glucose Level As Predictors of ICU Out Comes in Type 2 Diabetic Patients With Acute Heart Failure
NCT04922099
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The total incidence of DKA tends to increase, mainly due to an increase in type 2 diabetes cases and obesity.
DKA consists of the biochemical triad of hyperglycemia, ketonemia, and metabolic acidosis resulting from absolute or relative insulin deficiency and an increase in counter-regulatory hormones. These life-threatening consequences produce severe body water deficit, the accumulation of ketone bodies, and electrolyte disturbances.
Hyperglycemia develops because of three processes: increased gluconeogenesis, accelerated glycogenolysis, and impaired glucose utilization by peripheral tissues. The hyperglycemia will lead to glycosuria and osmotic diuresis, resulting in hyperosmolar intracellular dehydration.
In DKA, fluid deficits may be up to 10% of total body weight and electrolyte deficits in the body, one of which is chloride.
In DKA, lipolysis resulting in high circulating levels of free fatty acids may occur. These free fatty acids are taken up by the liver and oxidized to ketone bodies. Excessive production of ketone bodies in the anionic form can cause high plasma anion gap. Ketone bodies are relatively strong acids that dissociate at physiologic pH. The dissociation in the form of H+ ions will be buffered by bicarbonate. When the plasma bicarbonate concentrations decrease, a high anion gap acidosis metabolic (HAGMA) develops. The anion gap calculation formula is \[Na+ (Cl-+ HCO3)\]. Based on diagnostic criteria, the anion gap value in DKA \>10. The increased anion gap is a predictor of metabolic acidosis, and the degree of metabolic acidosis can be estimated by the size of the anion gap. Initial management of adult patients with DKA is rehydration with normal saline fluid (0.9% NaCl) intravenously and insulin administration (when the serum potassium levels \<3.3 mEq/L). The initial dose of normal saline infusion is 15-20 mL/kg/hour over the first hour.
Subsequent amount of fluid given depends on the hydration status, hemodynamic conditions, and electrolyte levels. Electrolyte levels are monitored after 2 hours of initial fluid resuscitation.
The goals of rapid rehydration are to improve the circulatory volume and tissue perfusion, clear ketone bodies, and correct electrolyte imbalances. Normal saline contains 154 mEq/L chloride and 154 mEq/L sodium.
The chloride concentration of saline is higher than that of human plasma (97-107 mEq/L).
Normal saline (0.9% sodium chloride) is a low-cost and easy-to-find crystalloid fluid which becomes fluid choice by doctors in some cases. However, normal saline is now under observation due to concerns about hyperchloremic metabolic acidosis, oliguria, prolonged acidosis, and coagulopathy. Consistent data are found regarding increased serum chloride levels associated with complications of acidosis, AKI, or electrolyte disturbances after being given at least 2 liters of normal saline. An increase in the chloride levels is not counterbalanced by an increase in the bicarbonate ion concentrations in plasma. Although the anion gap values decrease, acidosis still occurs. Thus, normal anion gap metabolic acidosis (NAGMA) or hyperchloremic acidosis arises.
Blood glucose level \<200 mg/dL, serum bicarbonate level \>15 mEq/L, pH \>7.3, and normal anion gap are recovery signs of DKA.12 causes of hyperchloremia include: Gastrointestinal problems, such as vomiting or diarrhea. heat exposure, Diabetes insipidus, Some medications, particularly hormones as estrogens, diuretics, corticosteroids,and certain,chemotherapy Starvation due to eating disorders, severe malnourishment, or problems absorbing nutrients from food.
Addison's disease, diabetes insipidus,burns, kidney disease, kidney failure, and renal tubular acidosis
Hypochloremia can be caused by:
Diarrhea Vomiting Excessive sweating Kidney problems Chronic respiratory acidosis, Syndrome of inappropriate antidiuretic hormone excretion (SIADH), Metabolic alkalosis, Use of certain medications like corticosteroids, diuretics, laxatives, and bicarbonates
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Blood glucose level \>250 mg/dl ( normal 70-100)
* Ph\<7.3 ( normal PH 7.35- 7.45)Hco3\<15 m mol/litre ( normal HCO3 22-26)
* Serum chloride before resucitation \<107m mol/litre (normal 96- 106)
* Urea \<6.5 m mol/litre
* S.create \<120 m mol/litre
Exclusion Criteria
* Patients diagnosed to have Addison disease
* Patients with chronic kidney disease and acute kidney injury, end stage renal disease, renal tubular acidosis
* Patients with malabsorpion syndrome ( celiac disease, crohn's , celiac disease )
* Patients with chronic respiratory acidosis (asthma, COPD, pulmonary fibrosis, neuromuscular disorders)
* Patients with diarrhea
15 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Mervat Mokhles Fathi Sayed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mervat Mokhles Fathi Sayed
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university hospitals
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Mokhles Fathy Sayed
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Assiut Hospitals, Master
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Serum chloride in DKA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.